Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Ascentage AAPG Stock Support and Resistance Momentum Fading 20260416 Relay Therapeutics RLAY Stock Stability Assessment Buying Pressure 20260418 Market Wrap Tech leads gains while consumer sector lags rally Should investors consider Our Bond OBAI stock right now Is Grupo SIM stock worth allocating capital to 098 20260420 OMF OneMain Holdings beats Q1 estimates but shares fall 154 on uncertain outlook signals AVPT AvePoint posts 269 percent year over year revenue growth and 10 percent EPS beat in Q4 2025 Cheche Group CCG Q4 2024 Beat Revenue NA EPS Exceeds by Significant UL Solutions ULS Crushes Q1 2026 Estimates EPS 050 Tops Views Roundhill Memory ETF Hits 10 Billion in Record Time as AI Memory Demand Surges Heartland Express Gains as Investor Sentiment Shifts Toward Trucking Recovery Paramount PZG Falls 473 Watching 134 Support 20260517 Retail Sales Growth Moderates in April as Rising Gas Prices Squeeze Consumer Spending South East Water Requests EssentialOnly Use as Demand Surges 100 Million Litres Disneys The Mandalorian and Grogu Posts Weakest Thursday Previews in Star Wars Franchise History Broadcom Meta and Industry Giants Invest 125 Million in UCLA Semiconductor Research Hub US Prioritizes AI Integration in Asia Following TrumpXi Summit Official Says Global Stock Markets Reach Record Highs as Oil Prices Slide on USIran Peace Hopes Kohls Sales Beat Expectations Can New Strategies Revive the Retailer ZDGE Q1 2026 Earnings EPS Misses Estimates Stock Declines 233 NET Q1 2026 Earnings EPS Beat Drives 9 Stock Surge Amidst Cloud Security Momentum Community Trust Bancorp Inc CTBI Q1 2026 Earnings Strong EPS Beat Driven by Solid Core Performance FOA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Transdigm Group TDG Q1 2026 Earnings EPS Surpasses Estimates as Core Markets Remain Strong PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses Fangdd Network Group DUO Edges Higher as Stock Tests Key Resistance Zone Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance Via Transportation VIA Edges Higher Amid Sector Momentum Key Levels in Focus